Picture of Metlife logo

MET Metlife News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsConservativeLarge CapSuper Stock

Street View: MetLife’s road ahead looks steady

** Insurance company MetLife MET.N reported higher Q3 profit on Wednesday, driven by increased investment income

MARGINS ON THE MEND

** J.P. Morgan ("overweight," PT: $93) expects co to deliver steady performance in its retirement business and continued growth in international sales

** Morgan Stanley ("overweight," PT: $97) views the strong rebound in earnings as a reflection of co's resilient business emphasizing the need to effectively manage investment portfolio risks and sustain earnings stability

** Evercore ISI ("outperform," PT: $108) says consistent underwriting and spread results were reassuring, with revenue growth momentum standing out as a key differentiator for MET vs. peers

** UBS ("buy," PT: $95) says group disability and supplemental lines, which faced margin pressure in H1 2025, will see improvement in Q4 from dental and seasonal trends

 (Reporting by Kanishka Ajmera in Bengaluru)

 ((Kanishka.Ajmera@thomsonreuters.com))

Recent news on Metlife

See all news